News Image

Why Quality Investors May Find NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Attractive.

By Mill Chart

Last update: May 3, 2024

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is suited for quality investing. Investors should of course do their own research, but we spotted NEUROCRINE BIOSCIENCES INC showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

Exploring Why NASDAQ:NBIX Holds Appeal for Quality Investors.

  • NEUROCRINE BIOSCIENCES INC has demonstrated significant revenue growth over the past 5 years, with a 33.13% increase. This underscores the company's ability to adapt to market dynamics and capitalize on growth opportunities.
  • The ROIC excluding cash and goodwill of NEUROCRINE BIOSCIENCES INC stands at 38.85%, reflecting the company's strong financial management and profitability. This metric underscores its ability to generate favorable returns on the capital invested in its core operations.
  • The Debt/Free Cash Flow Ratio of NEUROCRINE BIOSCIENCES INC stands at 0.47, reflecting the company's prudent capital structure and cash flow dynamics. This ratio highlights the company's ability to generate robust free cash flow relative to its debt obligations.
  • NEUROCRINE BIOSCIENCES INC exhibits impressive Profit Quality (5-year) with a 208.0% ratio, reflecting its consistent ability to generate high-quality profits. This metric underscores the company's strong financial performance and commitment to delivering sustainable earnings.
  • NEUROCRINE BIOSCIENCES INC has demonstrated consistent growth in EBIT over the past 5 years, with a strong 60.65%. This signifies the company's ability to generate sustainable earnings and reflects its positive financial trajectory.
  • NEUROCRINE BIOSCIENCES INC demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.

How does the complete fundamental picture look for NASDAQ:NBIX?

ChartMill utilizes a proprietary algorithm to assign a Fundamental Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of fundamental indicators and properties.

Overall NBIX gets a fundamental rating of 8 out of 10. We evaluated NBIX against 588 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making NBIX a very profitable company, without any liquidiy or solvency issues. NBIX is growing strongly while it also seems undervalued. This is an interesting combination These ratings could make NBIX a good candidate for value and growth and quality investing.

Check the latest full fundamental report of NBIX for a complete fundamental analysis.

Our Caviar Cruise screen will find you more ideas suited for quality investing.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

NEUROCRINE BIOSCIENCES INC

NASDAQ:NBIX (6/14/2024, 6:27:30 PM)

After market: 135.412 -0.04 (-0.03%)

135.45

-0.81 (-0.59%)

Follow us for more